Business Context and Reporting Period
This Form 8-K filing by BRC Inc. (BRCC) is dated June 18, 2025, with the report signed on June 20, 2025. The filing discloses a significant executive leadership change within the consumer-packaged goods sector, specifically the appointment of a new Chief Financial Officer and the departure of the incumbent.
Key Financial Metrics
The filing does not provide operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The financial data contained in this document is limited to the compensation package for the newly appointed executive:
- Base Salary: $500,000 annually.
- Target Bonus: 75% of base salary ($375,000 potential).
- Signing Bonus: $300,000.
- Equity Compensation: $1,000,000 aggregate value ($750,000 in stock options and $250,000 in restricted stock units).
Material Changes
The primary material change reported is the transition of the Chief Financial Officer role:
- Appointment: Matthew Amigh was appointed as Chief Financial Officer, effective July 7, 2025.
- Departure: Stephen Kadenacy served as CFO from September 18, 2023, through the effective date of the new appointment.
- Board Transition: Mr. Kadenacy was previously appointed to the Board of Directors on April 11, 2025, and will continue to serve as a director following his departure as CFO.
Outlook, Risks, and Management Commentary
Management commentary focuses on the qualifications of the new CFO, Mr. Amigh, highlighting his three decades of experience in the consumer-packaged goods industry, including roles at Ethos Pet Nutrition, Bulletproof 360, Inc., Lenny & Larry's, and Raybern Foods. His background includes leading companies through profitability returns and strategic sales. The filing notes that the equity awards vest in three equal annual installments subject to continued employment. No specific financial guidance, risks, or contingencies regarding the company's future performance are disclosed in this filing.
Investor Verification Checklist
- Verify the exact vesting schedule and performance metrics for the $375,000 target bonus in the full offer letter (to be filed in the Q2 2025 Form 10-Q).
- Confirm the exercise price of the $750,000 stock options based on the closing price on the grant date.
- Review the terms of the severance and restrictive covenant agreement referenced from the December 30, 2022, Form 8-K.
- Monitor the transition period between Mr. Kadenacy's departure and Mr. Amigh's start date (July 7, 2025) for any interim financial reporting impacts.